Infectious agents and inflammatory processes contribute to a range of heart diseases, some of which can lead to long-term cardiac complications if not treated adequately. Myocarditis, an inflammation of the heart muscle, and infective endocarditis, an infection of the heart valves, are among the most concerning infectious causes of heart disease. These conditions often present with nonspecific symptoms, making early diagnosis a challenge. Inflammatory responses, whether triggered by infections or autoimmune diseases, can disrupt the normal function of the heart, causing arrhythmias, heart failure, or even sudden cardiac death. Managing infections and inflammatory heart diseases typically requires a combination of antimicrobial treatments and anti-inflammatory medications, along with close monitoring to prevent further heart damage. Timely intervention can significantly improve prognosis and prevent the development of chronic heart conditions.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States